Craft

Shanghai Rendu Biotechnology

Stock Price

¥35.8

2024-10-29

Market Capitalization

¥1.4 B

2024-10-29

Revenue

¥174.9 M

FY, 2024

Shanghai Rendu Biotechnology Summary

Company Summary

Overview
Shanghai Rendu Biotechnology (上海仁度生物科技股份有限公司) is a company that specializes in the development and promotion of RNA molecular diagnostic technology and products. It offers products in the areas of reproductive health, respiratory diseases, enterovirus, food safety, and blood infectious diseases, as well as automatic nucleic acid detection and analysis system.
Type
Public
Status
Active
Founded
2007
Website
http://www.rdbio.com
Cybersecurity rating
Sectors

Table of Contents

Shanghai Rendu Biotechnology Financials

Summary Financials

Revenue (Q1, 2026)
¥41.5M
Gross profit (Q1, 2026)
¥31.5M
Net income (Q1, 2026)
¥5.0M
Cash (Q1, 2026)
¥93.8M
EBIT (Q1, 2026)
¥2.1M
Enterprise value
$1.3B

Footer menu